Diabetic kidney disease (DKD) is usually a clinical diagnosis in a patient with long standing diabetes (>10 years) with albuminuria and or reduced estimated glomerular filtration rate (eGFR) in the absence of signs or What are the guidelines for using DIHEXA PEPTIDE (Hexarelin) for growth hormone deficiency treatment? Frontiers Crosstalk of kidney and brain in diabetes related cognitive impairment and therapeutic strategies Hepatocyte Growth Factor MET Activator Rescues Working Memory Deficits after Repeated Mild Traumatic Brain Injury Katelyn A. Martino, Arush Nakhre, Renee M. Demarest, David M. Devilbiss, 2025 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York